new glp-1 weight loss A chapter in treatment is here. Meet Foundayo™ by Eli Lilly, the first FDA-approved oral GLP-1, designed to support through a convenient once-daily approach. Prescription-only treatment, with instant New oral GLP-1 drug delivers

For more information, call Wellmark at the number on your ID card or call Wellmark Customer Service

Pennsylvanias Medicaid program began covering the newer weight loss medications in 2023 when Wegovy was added to Medicaids list of preferred drugs for the treatment of obesity

PMID: 41877354

Integrating GLP-1 use with longitudinal, structured nutrition and lifestyle programming might also support simplified dose titration schedules and management of side effects

Its sequence is engineered to provide potent activity at the GIP receptor and balanced activity at the GLP-1 and GCG receptors

Potential preventive properties of GLP-1 receptor agonists against prostate cancer: a nationwide cohort study